Preclinical Development of a First-in-Class PCNA Inhibitor for Treating Neuroblastoma |
City of Hope National Medical Center / Linda Malkas, PhD |
Reach Grants |
2019 |
California |
Novel Therapy of Heterogeneous B-cell Acute Lymphocytic Leukemia by Targeting Convergent Oncogenic Mediators STATs |
University of Alberta / Hasan Uludag, PhD |
Innovation Grants |
2019 |
Alberta |
Generation of CMV-specific CD19 CAR T cells Using Cytokine Capture Followed by Lentiviral Transduction and Expansion |
Research Institute at Nationwide Children's Hospital / Margaret Lamb, MD |
Reach Grants |
2019 |
Ohio |
Role of the macro lncRNA KCNQ1OT1 in embryonal rhabdomyosarcoma tumorigenesis |
Duke University / Corinne Linardic, MD/PhD |
Innovation Grants |
2019 |
North Carolina |
Investigating phase separated condensates in FPD to MDS/AML progression |
Broad Institute / Zuzana Tothova, MD/PhD |
RUNX1 Early Career Investigator Grants |
2019 |
Massachusetts |
Epigenetic regulation of genomic instability and its therapeutic implications in T-cell acute lymphoblastic leukemia |
Dana-Farber Cancer Institute / Birgit Knoechel, MD/PhD |
Innovation Grants |
2019 |
Massachusetts |
Targeting Fusion-driven Sarcomas |
National Institutes of Health / Javed Khan, MD |
Crazy 8 Pilots |
2019 |
Maryland |
Intervention Development and Evaluation to Reduce Disparities in Quality of Life for Latino Families Impacted by Cancer |
The Regents of the University of California, Irvine / Michelle Fortier, PhD |
Psychosocial Family Impact Grant |
2019 |
California |
CD36-Sphingosine 1-Phosphate Axis in Osteosarcoma Progression |
Medical University of South Carolina / Meenal Mehrotra, MD/PhD |
Innovation Grants |
2019 |
South Carolina |
Targeting the Surface-ome of Embryonal Brain Tumors |
Institut Curie / Olivier Ayrault, PhD |
Crazy 8 Pilots |
2019 |
|